As a pioneer in the field of extracorporeal photopheresis (ECP) can you provide some background and history on how this therapeutic strategy was developed and for what challenging conditions, in particular, in CTCL?

As a pioneer in the field of extracorporeal photopheresis (ECP) can you provide some background and history on how this therapeutic strategy was developed and for what challenging conditions, in particular, in CTCL?

As a pioneer in the field of extracorporeal photopheresis (ECP) can you provide some background and history on how this therapeutic strategy was developed and for what challenging conditions, in particular, in CTCL?


Created by

CMEducation Resources IQ&A Extracorporeal Photopheresis Intelligence Zone | The Multi-Specialty Perspective

Presenter

Richard Edelson, MD

Richard Edelson, MD

Aaron B. and Marguerite Lerner Professor of Dermatology Chair and Professor Department of Dermatology Yale School of Medicine